Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Jul 2022 for Natus Medical INC.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Thomas Joseph Sullivan: trading record in brief
Thomas Joseph Sullivan, listed as chief executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Symmetry Medical Inc., Natus Medical Inc and Span America Medical Systems Inc. We count 30 filings; the first trade dates from 17 January 2011 and the latest from 21 July 2022.
No open-market purchase appears, only 1 sale worth €247k. Besides market trades, the filings include 23 share grants.
Most recently, on 21 July 2022, the filings show a transaction worth €23.6M in Natus Medical Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Joseph Sullivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
648,554 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000090:0
52,084 shares@ US$24.0089.7% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000004:0
5,214 shares@ US$28.7710.3% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000071:0
3 of 3 declarations
